## Correct Answer: C. Pannus formation and reactive lymphocytic infiltrate The clinical presentation of symmetrical small joint arthritis with positive anti-CCP antibodies is pathognomonic for rheumatoid arthritis (RA). Anti-CCP (anti-cyclic citrullinated peptide) is highly specific for RA and appears early in disease, often before clinical symptoms manifest. The histological hallmark of RA is **pannus formation**—a granulation tissue composed of proliferating synovial fibroblasts, endothelial cells, and a dense infiltrate of lymphocytes (predominantly CD4+ T cells and B cells), plasma cells, and macrophages. The pannus erodes cartilage and bone through production of matrix metalloproteinases and TNF-α. This reactive lymphocytic infiltrate is the immune driver of RA pathology. Early RA synovium shows hyperplasia of the synovial lining layer with increased vascularity; advanced disease shows the characteristic pannus with erosive changes. This distinguishes RA from other arthropathies at the histological level. The presence of anti-CCP confirms B-cell activation and autoimmunity directed against citrullinated proteins, which is central to RA pathogenesis in the Indian population, where RA prevalence is 0.75–1.2% and often presents in women aged 30–50 years. ## Why the other options are wrong **A. Synovial granulomas** — Synovial granulomas are NOT a feature of RA. Granulomas (both caseating and non-caseating) are seen in tuberculosis, sarcoidosis, and fungal infections—not in autoimmune arthritis. This is an NBE trap that conflates granulomatous inflammation with RA pathology. RA is characterized by lymphocytic infiltration and pannus, not granuloma formation. **B. Uric acid crystal deposits** — Uric acid crystal deposits (monosodium urate monohydrate) are the hallmark of gout, not RA. While both present with joint inflammation, gout is a crystal arthropathy triggered by hyperuricemia, typically affecting the first MTP joint acutely. Anti-CCP positivity rules out gout entirely. This option tests whether students confuse crystal arthropathies with autoimmune arthritis. **D. Non-caseating granulomas** — Non-caseating granulomas are characteristic of sarcoidosis and some infections (TB, fungal), not RA. While RA is an autoimmune disease, its histology is defined by pannus and lymphocytic infiltration, not granuloma formation. The presence of anti-CCP antibodies excludes granulomatous diseases and confirms RA as the diagnosis. ## High-Yield Facts - **Anti-CCP antibodies** are highly specific (95–98%) for RA and appear early, often before clinical symptoms; positive anti-CCP predicts erosive disease. - **Pannus** is a granulation tissue of proliferating fibroblasts, endothelial cells, and dense lymphocytic infiltrate that erodes cartilage and bone in RA. - **Symmetrical small joint arthritis** (PIP, MCP, wrist) is the classic presentation of RA; anti-CCP + symmetrical polyarthritis = RA until proven otherwise. - **Synovial hyperplasia and increased vascularity** occur early in RA; pannus formation and erosions develop in advanced disease. - **CD4+ T cells and B cells** dominate the lymphocytic infiltrate in RA synovium; TNF-α and IL-6 drive pannus proliferation and bone erosion. ## Mnemonics **RA Histology: PLE** **P**annus formation, **L**ymphocytic infiltrate, **E**rosion of cartilage and bone. This is the classic triad of RA histopathology. **Anti-CCP = RA** **Anti-CCP is to RA as RF is to RA, but anti-CCP is earlier and more specific.** If you see anti-CCP + symmetrical small joint arthritis, think RA pannus, not granulomas or crystals. ## NBE Trap NBE pairs granulomas (options A and D) with RA to trap students who conflate granulomatous inflammation (TB, sarcoidosis) with autoimmune arthritis. The anti-CCP clue is the discriminator: anti-CCP = RA = pannus + lymphocytes, never granulomas. ## Clinical Pearl In Indian clinical practice, RA presents in women aged 30–50 years with morning stiffness and symmetrical small joint swelling. Anti-CCP testing is now standard in Indian government and private hospitals; a positive anti-CCP with this presentation mandates DMARDs (methotrexate, biologics) early to prevent pannus-driven erosions and disability—early intervention is key in Indian RA management per IAP guidelines. _Reference: Robbins Ch. 6 (Diseases of Immunity); Harrison Ch. 312 (Rheumatoid Arthritis)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.